Swiss - Delayed Quote CHF

Aevis Victoria SA (AEVS.SW)

Compare
14.60 -0.15 (-1.02%)
At close: August 27 at 12:23 PM GMT+2
Loading Chart for AEVS.SW
DELL
  • Previous Close 14.75
  • Open 14.75
  • Bid 14.60 x --
  • Ask 14.70 x --
  • Day's Range 14.60 - 14.75
  • 52 Week Range 13.80 - 19.00
  • Volume 229
  • Avg. Volume 1,298
  • Market Cap (intraday) 1.23B
  • Beta (5Y Monthly) 0.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.47
  • Earnings Date Sep 19, 2024
  • Forward Dividend & Yield 0.45 (2.80%)
  • Ex-Dividend Date Sep 28, 2023
  • 1y Target Est 15.00

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Real Estate, and Others segments. It also provides telemedicine, ambulance, life sciences related services, patient hotel, radiology institute, pharmacy, ophthalmology, medical radiation, stem cells, cosmetics, parking, cleaning services, sterilization, and IT related services. In addition, the company operates urology center, health center, day clinics, and golf courses. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.

www.aevis.com

4,033

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AEVS.SW

View More

Performance Overview: AEVS.SW

Trailing total returns as of 8/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AEVS.SW
13.61%
MSCI WORLD
15.08%

1-Year Return

AEVS.SW
21.51%
MSCI WORLD
25.25%

3-Year Return

AEVS.SW
19.25%
MSCI WORLD
17.26%

5-Year Return

AEVS.SW
27.77%
MSCI WORLD
73.25%

Compare To: AEVS.SW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AEVS.SW

View More

Valuation Measures

Annual
As of 8/26/2024
  • Market Cap

    1.24B

  • Enterprise Value

    2.16B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.32

  • Price/Book (mrq)

    2.53

  • Enterprise Value/Revenue

    2.27

  • Enterprise Value/EBITDA

    40.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.72%

  • Return on Assets (ttm)

    -0.74%

  • Return on Equity (ttm)

    -7.98%

  • Revenue (ttm)

    833.01M

  • Net Income Avi to Common (ttm)

    -39.3M

  • Diluted EPS (ttm)

    -0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    80.71M

  • Total Debt/Equity (mrq)

    185.95%

  • Levered Free Cash Flow (ttm)

    -43.61M

Research Analysis: AEVS.SW

View More

Company Insights: AEVS.SW

Research Reports: AEVS.SW

View More

People Also Watch